Cargando…
Frailty Markers and Treatment Decisions in Patients Seen in Oncogeriatric Clinics: Results from the ASRO Pilot Study
BACKGROUND: Comprehensive Geriatric Assessment (CGA) is the gold standard to help oncologists select the best cancer treatment for their older patients. Some authors have suggested that the concept of frailty could be a more useful approach in this population. We investigated whether frailty markers...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769181/ https://www.ncbi.nlm.nih.gov/pubmed/26918947 http://dx.doi.org/10.1371/journal.pone.0149732 |
_version_ | 1782418066292867072 |
---|---|
author | Farcet, Anaïs de Decker, Laure Pauly, Vanessa Rousseau, Frédérique Bergman, Howard Molines, Catherine Retornaz, Frédérique |
author_facet | Farcet, Anaïs de Decker, Laure Pauly, Vanessa Rousseau, Frédérique Bergman, Howard Molines, Catherine Retornaz, Frédérique |
author_sort | Farcet, Anaïs |
collection | PubMed |
description | BACKGROUND: Comprehensive Geriatric Assessment (CGA) is the gold standard to help oncologists select the best cancer treatment for their older patients. Some authors have suggested that the concept of frailty could be a more useful approach in this population. We investigated whether frailty markers are associated with treatment recommendations in an oncogeriatric clinic. METHODS: This prospective study included 70 years and older patients with solid tumors and referred for an oncogeriatric assessment. The CGA included nine domains: autonomy, comorbidities, medication, cognition, nutrition, mood, neurosensory deficits, falls, and social status. Five frailty markers were assessed (nutrition, physical activity, energy, mobility, and strength). Patients were categorized as Frail (three or more frailty markers), pre-frail (one or two frailty markers), or not-frail (no frailty marker). Treatment recommendations were classified into two categories: standard treatment with and without any changes and supportive/palliative care. Multiple logistic regression models were used to analyze factors associated with treatment recommendations. RESULTS: 217 patients, mean age 83 years (± Standard deviation (SD) 5.3), were included. In the univariate analysis, number of frailty markers, grip strength, physical activity, mobility, nutrition, energy, autonomy, depression, Eastern Cooperative Oncology Group Scale of Performance Status (ECOG-PS), and falls were significantly associated with final treatment recommendations. In the multivariate analysis, the number of frailty markers and basic Activities of Daily Living (ADL) were significantly associated with final treatment recommendations (p<0.001 and p = 0.010, respectively). CONCLUSION: Frailty markers are associated with final treatment recommendations in older cancer patients. Longitudinal studies are warranted to better determine their use in a geriatric oncology setting. |
format | Online Article Text |
id | pubmed-4769181 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-47691812016-03-09 Frailty Markers and Treatment Decisions in Patients Seen in Oncogeriatric Clinics: Results from the ASRO Pilot Study Farcet, Anaïs de Decker, Laure Pauly, Vanessa Rousseau, Frédérique Bergman, Howard Molines, Catherine Retornaz, Frédérique PLoS One Research Article BACKGROUND: Comprehensive Geriatric Assessment (CGA) is the gold standard to help oncologists select the best cancer treatment for their older patients. Some authors have suggested that the concept of frailty could be a more useful approach in this population. We investigated whether frailty markers are associated with treatment recommendations in an oncogeriatric clinic. METHODS: This prospective study included 70 years and older patients with solid tumors and referred for an oncogeriatric assessment. The CGA included nine domains: autonomy, comorbidities, medication, cognition, nutrition, mood, neurosensory deficits, falls, and social status. Five frailty markers were assessed (nutrition, physical activity, energy, mobility, and strength). Patients were categorized as Frail (three or more frailty markers), pre-frail (one or two frailty markers), or not-frail (no frailty marker). Treatment recommendations were classified into two categories: standard treatment with and without any changes and supportive/palliative care. Multiple logistic regression models were used to analyze factors associated with treatment recommendations. RESULTS: 217 patients, mean age 83 years (± Standard deviation (SD) 5.3), were included. In the univariate analysis, number of frailty markers, grip strength, physical activity, mobility, nutrition, energy, autonomy, depression, Eastern Cooperative Oncology Group Scale of Performance Status (ECOG-PS), and falls were significantly associated with final treatment recommendations. In the multivariate analysis, the number of frailty markers and basic Activities of Daily Living (ADL) were significantly associated with final treatment recommendations (p<0.001 and p = 0.010, respectively). CONCLUSION: Frailty markers are associated with final treatment recommendations in older cancer patients. Longitudinal studies are warranted to better determine their use in a geriatric oncology setting. Public Library of Science 2016-02-26 /pmc/articles/PMC4769181/ /pubmed/26918947 http://dx.doi.org/10.1371/journal.pone.0149732 Text en © 2016 Farcet et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Farcet, Anaïs de Decker, Laure Pauly, Vanessa Rousseau, Frédérique Bergman, Howard Molines, Catherine Retornaz, Frédérique Frailty Markers and Treatment Decisions in Patients Seen in Oncogeriatric Clinics: Results from the ASRO Pilot Study |
title | Frailty Markers and Treatment Decisions in Patients Seen in Oncogeriatric Clinics: Results from the ASRO Pilot Study |
title_full | Frailty Markers and Treatment Decisions in Patients Seen in Oncogeriatric Clinics: Results from the ASRO Pilot Study |
title_fullStr | Frailty Markers and Treatment Decisions in Patients Seen in Oncogeriatric Clinics: Results from the ASRO Pilot Study |
title_full_unstemmed | Frailty Markers and Treatment Decisions in Patients Seen in Oncogeriatric Clinics: Results from the ASRO Pilot Study |
title_short | Frailty Markers and Treatment Decisions in Patients Seen in Oncogeriatric Clinics: Results from the ASRO Pilot Study |
title_sort | frailty markers and treatment decisions in patients seen in oncogeriatric clinics: results from the asro pilot study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769181/ https://www.ncbi.nlm.nih.gov/pubmed/26918947 http://dx.doi.org/10.1371/journal.pone.0149732 |
work_keys_str_mv | AT farcetanais frailtymarkersandtreatmentdecisionsinpatientsseeninoncogeriatricclinicsresultsfromtheasropilotstudy AT dedeckerlaure frailtymarkersandtreatmentdecisionsinpatientsseeninoncogeriatricclinicsresultsfromtheasropilotstudy AT paulyvanessa frailtymarkersandtreatmentdecisionsinpatientsseeninoncogeriatricclinicsresultsfromtheasropilotstudy AT rousseaufrederique frailtymarkersandtreatmentdecisionsinpatientsseeninoncogeriatricclinicsresultsfromtheasropilotstudy AT bergmanhoward frailtymarkersandtreatmentdecisionsinpatientsseeninoncogeriatricclinicsresultsfromtheasropilotstudy AT molinescatherine frailtymarkersandtreatmentdecisionsinpatientsseeninoncogeriatricclinicsresultsfromtheasropilotstudy AT retornazfrederique frailtymarkersandtreatmentdecisionsinpatientsseeninoncogeriatricclinicsresultsfromtheasropilotstudy |